Fresenius Medical Care Net Income
| FMS Stock | USD 22.70 0.18 0.80% |
As of the 31st of January, Fresenius Medical shows the Mean Deviation of 1.28, standard deviation of 1.93, and Variance of 3.71. Fresenius Medical Care technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm Fresenius Medical Care mean deviation, treynor ratio, as well as the relationship between the Treynor Ratio and kurtosis to decide if Fresenius Medical Care is priced favorably, providing market reflects its regular price of 22.7 per share. Given that Fresenius Medical has information ratio of (0.17), we urge you to verify Fresenius Medical Care's prevailing market performance to make sure the company can sustain itself at a future point.
Fresenius Medical Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 0.9958 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income | 852 M | 856.3 M | |
| Net Income Applicable To Common Shares | 618.6 M | 902.8 M | |
| Net Income From Continuing Ops | 666.8 M | 1.1 B | |
| Net Income Per Share | 0.82 | 0.79 | |
| Net Income Per E B T | 0.51 | 0.46 |
Fresenius | Net Income | Build AI portfolio with Fresenius Stock |
The evolution of Net Income for Fresenius Medical Care provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Fresenius Medical compares to historical norms and industry peers.
Latest Fresenius Medical's Net Income Growth Pattern
Below is the plot of the Net Income of Fresenius Medical Care over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Fresenius Medical Care financial statement analysis. It represents the amount of money remaining after all of Fresenius Medical Care operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Fresenius Medical's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Fresenius Medical's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 740.87 M | 10 Years Trend |
|
Net Income |
| Timeline |
Fresenius Net Income Regression Statistics
| Arithmetic Mean | 895,557,898 | |
| Geometric Mean | 773,533,571 | |
| Coefficient Of Variation | 45.91 | |
| Mean Deviation | 288,389,863 | |
| Median | 859,366,200 | |
| Standard Deviation | 411,179,375 | |
| Sample Variance | 169068.5T | |
| Range | 1.9B | |
| R-Value | (0.03) | |
| Mean Square Error | 180207.1T | |
| R-Squared | 0.0007 | |
| Significance | 0.92 | |
| Slope | (2,207,834) | |
| Total Sum of Squares | 2705095.7T |
Fresenius Net Income History
Other Fundumenentals of Fresenius Medical Care
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Fresenius Medical Net Income component correlations
Fresenius Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Fresenius Medical is extremely important. It helps to project a fair market value of Fresenius Stock properly, considering its historical fundamentals such as Net Income. Since Fresenius Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Fresenius Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Fresenius Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
Is there potential for Health Care Providers & Services market expansion? Will Fresenius introduce new products? Factors like these will boost the valuation of Fresenius Medical. Market participants price Fresenius higher when confident in its future expansion prospects. Understanding fair value requires weighing current performance against future potential. All the valuation information about Fresenius Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.295 | Dividend Share 1.44 | Earnings Share 1.47 | Revenue Per Share | Quarterly Revenue Growth 0.026 |
Fresenius Medical Care's market price often diverges from its book value, the accounting figure shown on Fresenius's balance sheet. Smart investors calculate Fresenius Medical's intrinsic value—its true economic worth—which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since Fresenius Medical's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Fresenius Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Fresenius Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fresenius Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Fresenius Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Fresenius Medical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Fresenius Medical.
| 11/02/2025 |
| 01/31/2026 |
If you would invest 0.00 in Fresenius Medical on November 2, 2025 and sell it all today you would earn a total of 0.00 from holding Fresenius Medical Care or generate 0.0% return on investment in Fresenius Medical over 90 days. Fresenius Medical is related to or competes with Universal Health, Tenet Healthcare, Encompass Health, DaVita HealthCare, Smith Nephew, Royalty Pharma, and Hologic. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally More
Fresenius Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Fresenius Medical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Fresenius Medical Care upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.17) | |||
| Maximum Drawdown | 10.14 | |||
| Value At Risk | (3.83) | |||
| Potential Upside | 3.0 |
Fresenius Medical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Fresenius Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Fresenius Medical's standard deviation. In reality, there are many statistical measures that can use Fresenius Medical historical prices to predict the future Fresenius Medical's volatility.| Risk Adjusted Performance | (0.1) | |||
| Jensen Alpha | (0.35) | |||
| Total Risk Alpha | (0.42) | |||
| Treynor Ratio | (0.22) |
Fresenius Medical January 31, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.1) | |||
| Market Risk Adjusted Performance | (0.21) | |||
| Mean Deviation | 1.28 | |||
| Coefficient Of Variation | (715.44) | |||
| Standard Deviation | 1.93 | |||
| Variance | 3.71 | |||
| Information Ratio | (0.17) | |||
| Jensen Alpha | (0.35) | |||
| Total Risk Alpha | (0.42) | |||
| Treynor Ratio | (0.22) | |||
| Maximum Drawdown | 10.14 | |||
| Value At Risk | (3.83) | |||
| Potential Upside | 3.0 | |||
| Skewness | (1.26) | |||
| Kurtosis | 4.27 |
Fresenius Medical Care Backtested Returns
Fresenius Medical Care secures Sharpe Ratio (or Efficiency) of -0.11, which denotes the company had a -0.11 % return per unit of risk over the last 3 months. Fresenius Medical Care exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Fresenius Medical's Variance of 3.71, mean deviation of 1.28, and Standard Deviation of 1.93 to check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.3, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Fresenius Medical will likely underperform. At this point, Fresenius Medical Care has a negative expected return of -0.22%. Please make sure to confirm Fresenius Medical's treynor ratio, as well as the relationship between the kurtosis and day typical price , to decide if Fresenius Medical Care performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.28 |
Poor predictability
Fresenius Medical Care has poor predictability. Overlapping area represents the amount of predictability between Fresenius Medical time series from 2nd of November 2025 to 17th of December 2025 and 17th of December 2025 to 31st of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Fresenius Medical Care price movement. The serial correlation of 0.28 indicates that nearly 28.0% of current Fresenius Medical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.28 | |
| Spearman Rank Test | 0.51 | |
| Residual Average | 0.0 | |
| Price Variance | 0.79 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Fresenius Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Fresenius Medical Care reported net income of 740.87 M. This is 117.08% higher than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The net income for all United States stocks is 29.75% lower than that of the firm.
Fresenius Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Fresenius Medical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Fresenius Medical could also be used in its relative valuation, which is a method of valuing Fresenius Medical by comparing valuation metrics of similar companies.Fresenius Medical is currently under evaluation in net income category among its peers.
Fresenius Medical Current Valuation Drivers
We derive many important indicators used in calculating different scores of Fresenius Medical from analyzing Fresenius Medical's financial statements. These drivers represent accounts that assess Fresenius Medical's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Fresenius Medical's important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Market Cap | 33.4B | 17.9B | 11.3B | 12.9B | 11.6B | 11.5B | |
| Enterprise Value | 41.5B | 45.3B | 29.8B | 22.7B | 20.4B | 16.5B |
Fresenius Medical ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Fresenius Medical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Fresenius Medical's managers, analysts, and investors.Environmental | Governance | Social |
Fresenius Medical Institutional Holders
Institutional Holdings refers to the ownership stake in Fresenius Medical that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Fresenius Medical's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Fresenius Medical's value.| Shares | Envestnet Asset Management Inc | 2025-06-30 | 374 K | Bank Of America Corp | 2025-06-30 | 337.3 K | Millennium Management Llc | 2025-06-30 | 308.4 K | Abc Arbitrage Sa | 2025-06-30 | 229.4 K | Qube Research & Technologies | 2025-06-30 | 199.6 K | Quantinno Capital Management Lp | 2025-06-30 | 182.2 K | Moran Wealth Management Llc | 2025-06-30 | 149.6 K | Fmr Inc | 2025-06-30 | 143.4 K | Nia Impact Capital | 2025-06-30 | 122.2 K | Pzena Investment Management, Llc | 2025-06-30 | 14.7 M | Fiduciary Management, Inc. Of Milwaukee | 2025-06-30 | 5.7 M |
Fresenius Fundamentals
| Return On Equity | 0.0632 | ||||
| Return On Asset | 0.0333 | ||||
| Profit Margin | 0.04 % | ||||
| Operating Margin | 0.10 % | ||||
| Current Valuation | 23.43 B | ||||
| Shares Outstanding | 579.7 M | ||||
| Shares Owned By Institutions | 8.05 % | ||||
| Number Of Shares Shorted | 1.76 M | ||||
| Price To Earning | 6.53 X | ||||
| Price To Book | 0.84 X | ||||
| Price To Sales | 0.67 X | ||||
| Revenue | 19.34 B | ||||
| Gross Profit | 4.91 B | ||||
| EBITDA | 3.21 B | ||||
| Net Income | 740.87 M | ||||
| Cash And Equivalents | 342.86 M | ||||
| Cash Per Share | 1.75 X | ||||
| Total Debt | 11 B | ||||
| Debt To Equity | 0.88 % | ||||
| Current Ratio | 1.18 X | ||||
| Book Value Per Share | 53.50 X | ||||
| Cash Flow From Operations | 2.39 B | ||||
| Short Ratio | 4.66 X | ||||
| Earnings Per Share | 1.47 X | ||||
| Price To Earnings To Growth | 0.35 X | ||||
| Target Price | 28.52 | ||||
| Number Of Employees | 109.92 K | ||||
| Beta | 0.97 | ||||
| Market Capitalization | 13.15 B | ||||
| Total Asset | 33.57 B | ||||
| Retained Earnings | 11.27 B | ||||
| Working Capital | 2.26 B | ||||
| Current Asset | 6.98 B | ||||
| Current Liabilities | 4.19 B | ||||
| Annual Yield | 0.04 % | ||||
| Five Year Return | 1.29 % | ||||
| Net Asset | 33.57 B | ||||
| Last Dividend Paid | 1.44 |
About Fresenius Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Fresenius Medical Care's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Fresenius Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Fresenius Medical Care based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Fresenius Stock Analysis
When running Fresenius Medical's price analysis, check to measure Fresenius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius Medical is operating at the current time. Most of Fresenius Medical's value examination focuses on studying past and present price action to predict the probability of Fresenius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius Medical's price. Additionally, you may evaluate how the addition of Fresenius Medical to your portfolios can decrease your overall portfolio volatility.